Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature

BACKGROUND: Immune checkpoint inhibitors are a new promising class of antitumor drugs that have been associated with a number of immune-related Adverse Events (AEs), including musculoskeletal and rheumatic disease. METHODS: We searched Medline reviewing reports of musculoskeletal and rheumatic AEs i...

Descripción completa

Detalles Bibliográficos
Autores principales: Benfaremo, Devis, Manfredi, Lucia, Luchetti, Michele Maria, Gabrielli, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198478/
https://www.ncbi.nlm.nih.gov/pubmed/29745339
http://dx.doi.org/10.2174/1574886313666180508122332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198478/
https://www.ncbi.nlm.nih.gov/pubmed/29745339
http://dx.doi.org/10.2174/1574886313666180508122332

Ejemplares similares